Over the past year there were no insider purchases at Caribou Biosciences, Inc.. Four insiders sold roughly $47,000 instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. On the institutional side, 137 funds reported holding CRBU at the end of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Kelly Timothy P | Executive Officer | Sell | 6,228 | $1.93 | $12K | SEC |
| Feb 24, 2026 | Kelly Timothy P | Executive Officer | Sell | 3,147 | $1.96 | $6K | SEC |
| Feb 24, 2026 | MCCLUNG BARBARA G | Executive Officer | Sell | 6,938 | $1.96 | $14K | SEC |
| Feb 24, 2026 | Khan Ruhi Ahmad | Executive Officer | Sell | 6,938 | $1.96 | $14K | SEC |
| Feb 24, 2026 | Albertson Tina M. | Executive Officer | Sell | 1,066 | $1.96 | $2K | SEC |
| Mar 17, 2025 | Haurwitz Rachel E. | CEO | Buy | 20,000 | $1.02 | $20K | SEC |
| Feb 21, 2025 | MCCLUNG BARBARA G | Executive Officer | Sell | 3,564 | $1.35 | $5K | SEC |
| Feb 21, 2025 | Khan Ruhi Ahmad | Executive Officer | Sell | 3,564 | $1.35 | $5K | SEC |
| Feb 21, 2025 | Kanner Steven | Executive Officer | Sell | 3,564 | $1.35 | $5K | SEC |
| Jan 30, 2025 | Ryali Sriram | CFO | Buy | 17,360 | $1.42 | $25K | SEC |
| Jan 20, 2023 | Rizvi Syed Ali-aamir | Executive Officer | Sell | 5,627 | $6.31 | $36K | SEC |
In the last 12 months Caribou Biosciences, Inc. insiders made open-market purchases worth about $0 and sales worth about $47,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in CRBU was filed on 2026-02-27.
137 investment managers reported holding CRBU in SEC Form 13F filings for Q2 2026.
No congressional trades in CRBU were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).